Skip to main content

Table 1 Demographics of subjects in the poor and good outcomes groups

From: Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss

Outcomes

Poor (n = 93)

Good (n = 100)

P value

Age (mean ± SD, y/o)

38.8 ± 10.9

38.9 ± 10.7

0.93041

Sex (n, %)

Male

60(64.5)

64(64.0)

0.94042

Female

33(35.5)

36(36.0)

 

Hearing loss type

High

18(19.4)

10(10.0)

0.15562

Flat

64(68.8)

74(74.0)

 

Total

11(11.8)

16(16.0)

 

PTA (mean ± SD, dB)

Pre-treatment

68.83 ± 24.03

62.71 ± 21.00

0.06051

Post-treatment

56.08 ± 20.56

28.43 ± 16.84

 < 0.0001*1

Change in hearing level

6.63 ± 12.43

40.40 ± 18.94

 < 0.0001*1

SRT (mean ± SD, dB)

Pre-treatment

64.38 ± 25.52

56.75 ± 29.31

0.11741

Post-treatment

52.61 ± 26.28

37.15 ± 27.44

0.0013*1

SDS (mean ± SD, %)

Pre-treatment

55.39 ± 36.17

62.65 ± 39.00

0.27321

Post-treatment

63.22 ± 37.46

82.52 ± 30.03

0.0013*1

  1. 1 Independent t-test
  2. 2 χ2 test
  3. *P < 0.05
  4. Pure-tone average (PTA) by average of pure-tone hearing threshold by air conduction at 0.5, 1, 2, and 3 kHz
  5. Abbreviations: pure-tone average (PTA), speech discrimination score (SDS), speech reception threshold (SRT)